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Streptolydigin is a potent inhibitor of bacterial RNA polymerase with limited cross-resistance with other inhibitors such as
rifampicin, thus making streptolydigin a good candidate for the development of antibacterial derivatives with improved
antibiotic activity. Since streptolydigin has been also described as potential antitumor agent, the opportunity for developing
derivatives with enhanced antitumor activity seems promising. The characterization of the streptolydigin gene cluster from
Streptomyces lydicus, reported now by Olano et al., has shown its tetramic acid moiety being synthesized by a hybrid
type I PKS-NRPS system, and the use of combinatorial biosynthesis has allowed the generation of several novel glycosylated
derivatives with antibacterial activity.
OMG, MGL! They Found What?
PAGE 1045
Monoacylglycerol lipase (MGL) is the primary enzyme respon-
sible for the deactivation of the endocannabinoid 2-arachido-
noyl-sn-glycerol (2-AG). Previous studies in rodent models
suggest that blockade of MGL produces antinociception.
All currently available MGL inhibitors exert their effects by
forming covalent bonds with the enzyme and may therefore
carry potential clinical disadvantages through this irreversible
mode of action. In the present study, King and colleagues
screened a commercial chemical library to identify two bioisos-
teric terpenoids that inhibit MGL through a rapidly reversible
mechanism and may thus serve as starting points for the
further development of MGL as a therapeutic target.
Blood-Feeding Ticks Meet Proteomics
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Hemoglobin digestion is an essential process for blood-feeding parasites. We deconvoluted the hemoglobinolytic cascade in
the tick Ixodes ricinus, a vector of Lyme disease and tick-borne encephalitis. Horn et al. demonstrate the role of a network of
digestive peptidases through imaging with specific activity-based probes and activity profiling. Selective inhibitors were
applied to dissect the roles of the individual peptidases and determine the peptidase-specific cleavage map of the hemo-
globin molecule. Because of their central function in nutrition of the parasite, the identified enzymes are potential targets
to developing novel antitick vaccines that limit parasite survival and disease transmission.
When LovD Turns to Serious Synthesis
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Simvastatin is the active pharmaceutical ingredient of the block-
buster cholesterol-lowering drug Zocor. In this work, Gao et al.
employed directed evolution to engineer the acyltransferase
LovD to be an efficient simvastatin synthase. Improved mutants
were obtained through directed evolution, and the best mutant
displaying a 11-fold increase in whole cell biosynthesis of sim-
vastatin acid was compared to the parent LovD. In addition,
seven crystal structures of LovD (parent, mutant, and cocrystal
with ligands) were determined. This collection of structures
enhanced our understanding of the catalytic mechanism of
LovD and afforded insights into how beneficial mutations
improved the catalytic properties of LovD. The successful rede-
sign of LovD into a simvastatin synthase demonstrates the vast
potential of utilizing enzymes involved in secondary metabolism
as useful biocatalysts.Chemistry & Biology 16, October 30, 2009 ª2009 Elsevier Ltd All rights reserved ix
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DNA-encoded chemical libraries are promising tools for the
discovery of binders towards protein targets of pharmaceutical
relevance. DNA-encoded small molecules can be enriched in
affinity-based selections and their unique DNA ‘‘barcode’’ allows
the amplification and identification by high-throughput sequencing.
In the approach described by Buller et al., ligandswere selected out
of 4000DNA-encoded compounds generated byDiels-Alder cyclo-
additions against trypsin, human serum albumin, the anti-apoptotic
Bcl-xL protein, and tumor necrosis factor (TNF). Sequence enrich-
ment profiles corresponding to the ‘‘barcoded’’ library members
were validated by affinity measurements of single compounds,
revealing a novel class of TNF binders, which completely inhibited
TNF-mediated killing of L-M fibroblasts in vitro. The approach
might provide an alternative to conventional small molecule high-
throughput screening as it lays a foundation for manipulating large
DNA-encoded chemical libraries.
Ribosome under Attack
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The thiopeptide antibiotics thiostrepton (ThS) and nosiheptide (NoS) target the ribosome and inhibit translation factor func-
tion, whereas GE2270A/T binds to elongation factor EF-Tu and prevents ternary complex formation. Using several in vitro
translational machinery assays to screen a library of thiopeptide antibiotic precursor compounds, Starosta et al. identified
four families of compounds that are either themselves inhibitory or relieve the inhibitory effects of ThS, NoS, or GE2270T.
Some of these precursors represent distinct compounds with respect to their ability to bind to ribosomes, demonstrating
the potential of such assays for identifying lead compounds that might be missed using conventional inhibitory screening
protocols.
La Dolce Vita: Removing a Roadblock in Glycosynthase Startegy
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Carbohydrate synthesis, not regulated by universally conserved codes, is signifi-
cantly more complex, conceptually and practically, than nucleic acids and protein
synthesis. Cellular polysaccharides are endowed with breathtaking structural
variety and the diverse stereochemistry of the monosaccharide building blocks.
The advent of glycosynthases, glycoside hydrolases mutants able to synthesize
sugars, could, in principle, overcome some problems surrounding chemical
synthesis strategies, if these engineered enzymes are applied to obtain polysac-
charides of desired structure and composition. However, only b-glycosynthases
could be reliably produced so far. Cobucci-Ponzano et al. now show an approach
to prepare two a-fucosynthases that efficiently produce fucosylated oligosaccha-
rides of biotechnological interest. The strategy relies on the use of glycoside azide
derivatives. The methodology is of general applicability, thus expanding the glyco-
synthetic approach to the entire class of a-glycosidases.
Amination of Polyketide Starter Unit
PAGE 1109
Analyses of the gene cluster for the biosynthesis of a cytotoxic macrolactam,
elaborated on in this issue by Jørgensen et al., provides exciting insights into the
general questions surrounding biosynthesis of natural products. The authors
propose involvement of two distinct PKS systems, one functioning together with
NRPS-related enzymes. The synthesis of the polyketide starter and the manner
in which it is aminated represents a previously unobserved mechanism for generation of an acyl amino acid starter unit.
Understanding of the biosynthetic pathway, access to the genes, and the demonstrated possibility to manipulate them
open new possibilities for modification of the macrolactammolecule and generation of novel analogs with improved pharma-
cological properties.
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